Skip to main navigation Skip to search Skip to main content

Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study

  • Seoyun Han
  • , Sun Young Kim
  • , Young Eun Jung
  • , Won Kim
  • , Jeong Seok Seo
  • , Inki Sohn
  • , Kwanghun Lee
  • , Jong Hun Lee
  • , Sang Keun Chung
  • , Sang Yeol Lee
  • , Jung Wan Hong
  • , Bo Hyun Yoon
  • , Young Sup Woo
  • , Changwoo Han
  • , Jhin Goo Chang
  • , Won Myong Bahk
  • , Hoo Rim Song
  • , Minha Hong
  • Hanyang University
  • National Cancer Center Korea
  • Jeju National University
  • Inje University
  • Chung-Ang University
  • Keyo Hospital
  • Dongguk University
  • Catholic University of Daegu
  • Jeonbuk National University
  • Wonkwang University
  • Iksan Hospital
  • Naju National Hospital
  • University of North Carolina at Chapel Hill

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objective We aimed to identify the expectations and preferences for medication and medical decision-making in patients with major psychiatric disorders. Methods A survey was conducted among patients with major psychiatric disorders who visited psychiatric outpatient clinics at 15 hos-pitals between 2016 and 2018 in Korea. The survey consisted of 12 questions about demographic variables and opinions on their expectations for medication, important medical decision-makers, and preferred drug type. The most preferred value in each category in the total population was identified, and differences in the preference ratio of each item among the disease groups were compared. Results A total of 707 participants were surveyed. In the total population, patients reported high efficacy (44.01%±21.44%) as the main wish for medication, themselves (37.39%±22.57%) and a doctor (35.27%±22.88%) as the main decision makers, and tablet/capsule (36.16%±30.69%) as the preferred type of drug. In the depressive disorders group, the preference ratio of high efficacy was significantly lower, and the preference ratio of a small amount was significantly higher than that of the psychotic disorder and bipolar disorder groups. The preference ratio of a doctor as an important decision maker in the bipolar disorder group was higher compared to the other groups. Conclusion This study revealed the preference for medications and showed differences among patients with psychiatric disorders. Pro-viding personalized medicine that considers a patient’s preference for the drug may contribute to the improvement of drug compliance and outcomes.

Original languageEnglish
Pages (from-to)28-36
Number of pages9
JournalPsychiatry Investigation
Volume21
Issue number1
DOIs
StatePublished - Jan 2024

Bibliographical note

Publisher Copyright:
© 2024 Korean Neuropsychiatric Association.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Decision making
  • Mental illness
  • Patient preference
  • Pharmacotherapy

Fingerprint

Dive into the research topics of 'Patient’s Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study'. Together they form a unique fingerprint.

Cite this